SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-300729
Filing Date
2014-08-07
Accepted
2014-08-07 16:17:16
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d752295d10q.htm 10-Q 607190
2 EX-31.1 d752295dex311.htm EX-31.1 6533
3 EX-31.2 d752295dex312.htm EX-31.2 6567
4 EX-32.1 d752295dex321.htm EX-32.1 4093
  Complete submission text file 0001193125-14-300729.txt   4166090

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT alxa-20140630.xml EX-101.INS 543562
6 XBRL TAXONOMY EXTENSION SCHEMA alxa-20140630.xsd EX-101.SCH 37900
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxa-20140630_cal.xml EX-101.CAL 58000
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alxa-20140630_def.xml EX-101.DEF 129305
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxa-20140630_lab.xml EX-101.LAB 328535
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxa-20140630_pre.xml EX-101.PRE 235237
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51820 | Film No.: 141024144
SIC: 2834 Pharmaceutical Preparations